Clinical aspects of pandemic 2009 influenza a (H1N1) virus infection

New England Journal of Medicine

Volumn 362, Issue 18, 2010, Pages 1708-

  Bautista, Edgar ^a   Chotpitayasunondh, Tawee ^b   Gao, Zhancheng ^c   Harper, Scott A ^d   Shaw, Michael ^d   Uyeki, Timothy M ^d   Zaki, Sherif R ^d   Hayden, Frederick G ^e,f   Hui, David S ^g   Kettner, Joel D ^h   Kumar, Anand ^h   Lim, Matthew ⁱ   Shindo, Nahoko ⁱ   Penn, Charles ⁱ   Nicholson, Karl G ^j  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b QUEEN SIRIKIT NATIONAL INSTITUTE OF CHILD HEALTH   (Thailand)

^c PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h UNIVERSITY OF MANITOBA   (Canada)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; PERAMIVIR; ZANAMIVIR;

ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; CLINICAL FEATURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG TOLERABILITY; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 77951788536     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1000449     Document Type: Review

References (85)

1. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, et al. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009;374:2072-2079
2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689
3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615 [Erratum, N Engl J Med 2009;361:102.]
4. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-201.
5. Pandemic (H1N1) 2009 - update 94. Geneva: World Health Organization, April 1, 2010. (Accessed April 9, 2010, at http://www.who.int/csr/don/2010-04- 01/en/index.html.)
6. CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-February 13, 2010. Atlanta: Centers for Disease Control and Prevention, 2010. (Accessed April 9, 2010, at http://flu.gov/ individualfamily/about/h1n1/estimates-2009-h1n1.html.)
7. Recommended composition of influenza virus vaccines for use in the 2010 influenza season (southern hemisphere winter). Wkly Epidemiol Rec 2009;84:421-431
8. Valli MB, Meschi S, Selleri M, et al. Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. PLoS Curr Influenza 2010:March 3:RRN1149.
9. Maines TR, Jayaraman A, Belser JA, et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 2009;325:484-487
10. Itoh Y, Shinya K, Kiso M, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025
11. Munster VJ, de Wit E, van den Brand JM, et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009;325:481-483
12. Reed C, Angulo FJ, Swerdlow DL, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April-July 2009. Emerg Infect Dis 2009;15:2004-2007
13. Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2009;339:b5213.
14. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100-1108
15. Baker MG, Wilson N, Huang QS, et al. Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill 2009;14:pii19319.
16. Pandemic (H1N1) 2009 in England: an overview of initial epidemiological findings and implications for the second wave. London: Health Protection Agency, 2009.
17. Ross T, Zimmer S, Burke D, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza 2010;February 24:RRN1148.
18. Mathematical modelling of the pandemic H1N1 2009. Wkly Epidemiol Rec 2009;84:341-348
19. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 2009;14:pii19255.
20. Fraser C, Donnelly CA, Cauchemez S, et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 2009;324:1557-1561
21. Presanis AM, De Angelis D, Hagy A, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 2009;6(12):e1000207.
22. Transmission dynamics and impact of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec 2009;84:481-484
23. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009;302:1896-1902
24. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-1944
25. Domínguez-Cherit G, Lapinsky SE, Macias AE, et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-1887
26. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-1934
27. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009;302:1872-1879
28. Cauchemez S, Donnelly CA, Reed C, et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009;361:2619-2627
29. France AM, Jackson M, Schrag S, et al. Household transmission of 2009 influenza A (H1N1) virus after a school-based outbreak in New York City, April-May 2009. J Infect Dis 2010;201:984-992
30. Witkop CT, Duffy MR, Macias EA, et al. Novel influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. Am J Prev Med 2010;38:121-126
31. Lessler J, Reich NG, Cummings DA, et al. Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school. N Engl J Med 2009;361:2628-2636
32. Yang Y, Sugimoto JD, Halloran ME, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science 2009;326:729-733
33. White LF, Wallinga J, Finelli L, et al. Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses 2009;3:267-276
34. Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010;362:45-55.
35. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27-35.
36. Jamieson DJ, Honein MA, Rasmussen SA, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-458
37. Archer B, Cohen C, Naidoo D, et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill 2009;14:pii19639.
38. Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010;5(3):e9694.
39. Zarychanski R, Stuart TL, Kumar A, et al. Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection. CMAJ 2010;182:257-264
40. Childs RA, Palma AS, Wharton S, et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 2009;27:797-799
41. Chan MC, Chan RW, Yu WC, et al. Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 2010;176:1828-1840
42. To KK, Chan KH, Li IW, et al. Viral load in patients infected with pandemic H1N1 2009 influenza A virus. J Med Virol 2010;82:1-7.
43. De Serres G, Rouleau I, Hamelin M-E, et al. Contagious period for pandemic (H1N1) 2009. Emerg Infect Dis 2010 May (Epub ahead of print).
44. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010;50:850-859
45. Lee N. Pathogenesis of pandemic H1N1 in humans. Presented at the XII International Symposium on Respiratory Viral Infections, Taipei, Taiwan, March 11-14, 2010. abstract.
46. Fleury H, Burrel S, Balick Weber C, et al. Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009. Euro Surveill 2009;14:pii19434.
47. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009;13:R201.
48. Osterlund P, Pirhonen J, Ikonen N, et al. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 2010;84:1414-1422
49. Perez CM, Ferres M, Labarca JA. Pandemic (H1N1) 2009 reinfection, Chile. Emerg Infect Dis 2010;16:156-157
50. Shieh WJ, Blau DM, Denison AM, et al. Pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the U.S. Am J Pathol (in press).
51. Gill JR, Sheng Z, Ely SF, et al. Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. Arch Pathol Lab Med 2010;134:225-243
52. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72-79
53. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009;361:2507-2517
54. Estadísticas: influenza A (H1N1). Mexico City: Secretaria de Salud, May 29, 2009. (Accessed April 9, 2010, at http://portal.salud.gob.mx/ contenidos/noticias/influenza/estadisticas.html.)
55. Shimada T, Gu Y, Kamiya H, et al. Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill 2009;14:pii19244.
56. Hackett S, Hill L, Patel J, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet 2009;374:605.
57. Human infection with new influenza A (H1N1) virus: clinical observations from Mexico and other affected countries, May 2009. Wkly Epidemiol Rec 2009;84:185-189
58. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. Geneva: World Health Organization, November 2009. (Accessed April 9, 2010, at http://www.who.int/csr/resources/publications/swineflu/clinical- management/en/index.html.)
59. Noriega LM, Verdugo RJ, Araos R, et al. Pandemic influenza A (H1N1) 2009 with neurological manifestations, a case series. Influenza Other Respir Viruses 2010 February 24 (Epub ahead of print).
60. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet 2009;374:605-607
61. Larcombe PJ, Moloney SE, Schmidt PA. Pandemic (H1N1) 2009: a clinical spectrum in the general paediatric population. Arch Dis Child 2009 November 10 (Epub ahead of print).
62. Dulyachai W, Makkoch J, Rianthavorn P, et al. Perinatal pandemic (H1N1) 2009 infection, Thailand. Emerg Infect Dis 2010;16:343-344
63. Kidd IM, Down J, Nastouli E, et al. H1N1 pneumonitis treated with intravenous zanamivir. Lancet 2009;374:1036.
64. Gaur AH, Bagga B, Barman S, et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010;362:88-89
65. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009;4(12):e8540.
66. Blyth CC, Iredell JR, Dwyer DE. Rapid-test sensitivity for novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;361:2493.
67. Li IW, Chan KH, To KW, et al. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol 2009;46:325-330
68. Lim ML, Chong CY, Tee WS, Lim WY, Chee JJ. Influenza A/H1N1 (2009) infection in pregnancy - an Asian perspective. BJOG 2010 February 10 (Epub ahead of print).
69. WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Geneva: World Health Organization, February 2010. (Accessed April 9, 2010, at http://www.who.int/csr/resources/ publications/swineflu/h1n1-use-antivirals-20090820/en/index.html.)
70. Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. MMWR Morb Mortal Wkly Rep 2010;58:1436-1440
71. Redelman-Sidi G, Sepkowitz KA, Huang CK, et al. H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010;60:257-263
72. Perez C, Dominguez MI, Ceballos ME, Moreno C. Pandemic influenza A (H1N1) in HIV-1-infected patients. Presented at the 47th annual meeting of the Infectious Diseases Society of America, Philadelphia, October 27-November 1, 2009. abstract.
73. Kamigaki T, Oshitani H. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan. PLoS Curr Influenza 2009;December 20:RRN1139. (Accessed April 9, 2010, at http://knol.google.com/k/ taro-kamigaki/epidemiological-characteristics-andlow/38epug6fmizmk/1? collectionId=28qm4w0q65e4w.1&.)
74. Ling LM, Chow AL, Lye DC, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010;50:963-969
75. Recommendations for use of antiviral medications for the management of influenza in children and adolescent for the 2009-2010 season - pediatric supplement for health care providers. Atlanta: Centers for Disease Control and Prevention, December 2009. (Accessed April 9, 2010, at http://www.cdc.gov/ h1n1flu/recommendations-pediatric-supplement.htm.)
76. Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 2010;182:357-363
77. Kiatboonsri S, Kiatboonsri C, Theerawit P. Fatal respiratory events caused by zanamivir nebulization. Clin Infect Dis 2010;50:620.
78. Update on oseltamivir-resistant pandemic A (H1N1) 2009 influenza virus: January 2010. Wkly Epidemiol Rec 2009;85:37-40.
79. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 2010;362:86-87
80. Englund J, Zerr D, Heath J, et al. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Dispatch 2009;58:1-4.
81. Emergency use authorization of Peramivir IV: fact sheet for healthcare providers. Atlanta: Centers for Disease Control and Prevention, 2009. (Accessed April 9, 2010, at http://www.cdc.gov/h1n1flu/eua/ Final%20HCP%20Fact%20sheet%20Peramivir%20IV-CDC.pdf.)
82. Yazdanbakhsh M, Kremsner PG. Influenza in Africa. PLoS Med 2009;6(12):e1000182.
83. Bansal S, Pourbohloul B, Hupert N, Grenfell B, Meyers LA. The shifting demographic landscape of pandemic influenza. PLoS One 2010;5(2):e9360.
84. Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010;463:818-822
85. König R, Stertz S, Zhou Y, et al. Human host factors required for influenza virus replication. Nature 2010;463:813-817